Clinical trials are a critical phase in the drug development process, providing essential data on the safety and efficacy of new therapies. During clinical trials, drugs undergo rigorous testing across multiple phases, starting with small groups of healthy volunteers to assess safety and dosage. As the trial progresses, larger groups of patients are involved to evaluate the drug's effectiveness in treating specific conditions. Clinical trials also play a key role in understanding the pharmacokinetics and pharmacodynamics of new drugs, which helps in determining optimal dosages and administration methods. Advances in clinical trial design, such as adaptive trials and decentralized trials, are improving efficiency and patient recruitment. In addition, the integration of innovative drug delivery systems in clinical trials ensures that therapies are targeted precisely, offering better treatment outcomes and fewer side effects. Clinical trials remain the gold standard for bringing safe and effective new drugs to market.
Consolato M Sergi
Universities of Alberta and Ottawa, Canada
Vladlen Slepak
University of Miami Miller School of Medicine, United States
Andreas M Papas
Antares Health Products, United States
Sergey Suchkov
The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian FederationSubmit your abstract Today
Title : Medical liver biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G Protein-Coupled Receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Mathematical modeling the disc diffusion test: Antibacterial activity of copper-doped SnO2
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Emerging formulation and delivery applications of Vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through design-inspired biotech- & biopharma-driven applications and upgraded business marketing to secure the human healthcare and biosafety
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad Autónoma de Baja California, Mexico
Title : Macitentan/Tadalafil Combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Drug development - Importance, trends and digital transformation
Gurpreet Singh, IQVIA, United Kingdom
Title : Navigating the regulatory landscape for nanotechnology-based pharmaceuticals: challenges and strategies for harmonization
Srividya Narayanan, Northeastern University, United States